CSBR — CHAMPIONS ONCOLOGY, INC.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 771856 ·
Last close
$5.99
Market Cap
$83.11M
52W High
$6.39
52W Low
$5.50
ADV30
9,188
Next earnings
2026-03-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jan 2026 | 16,559,000 | 7,725,000 | -187,000 | -279,000 | 28,447,000 | 7,127,000 | 24,069,000 |
| Oct 2025 | 15,035,000 | 7,773,000 | 185,000 | 299,000 | 30,162,000 | 8,516,000 | 25,931,000 |
| Jul 2025 | 13,995,000 | 6,000,000 | -507,000 | -466,000 | 30,546,000 | 10,325,000 | 27,008,000 |
| Apr 2025 | 12,355,000 | 5,084,000 | -1,714,000 | -1,835,000 | 32,344,000 | 9,785,000 | 28,572,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$4,394,000
Investing CF
$-555,000
Financing CF
$86,000
CapEx
$-578,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.16
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-80,400,000
Inventory
—
Receivables
$12,067,000
ST Investments
—
EBIT TTM
$-2,223,000
Pretax Income TTM
$-2,398,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$57,945,000
EBITDA
$-772,000
Free Cash Flow
$4,702,375
Enterprise Value
$81,426,824
Total Cash
$7,127,000
Total Debt
$4,999,000
Shares Out
13,886,826
Trailing EPS
$-0.18
Book Value
$0.31
ROE
-47.6%
ROA
-4.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Apr 2025 | 56,944,000 | 4,846,000 | 4,701,000 | 32,344,000 | 28,572,000 | — | 7,386,000 |
| Apr 2024 | 50,155,000 | -6,921,000 | -7,276,000 | 26,132,000 | 28,035,000 | — | -6,137,000 |
| Apr 2023 | 53,870,000 | -4,449,000 | -5,335,000 | 34,311,000 | 29,675,000 | — | 3,972,000 |
| Apr 2022 | 49,109,000 | 607,000 | 548,000 | 35,378,000 | 26,282,000 | — | 6,497,000 |
TTM Snapshot
Revenues TTM
$14,061,000
NetIncome TTM
$1,313,000
OpCashFlow TTM
$0
Assets (Latest)
$32,344,000
Forward EPS
$0.10
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| EXOZ | EXOZYMES INC. | $84.03M | $9.91 | — |
| ATRA | Atara Biotherapeutics, Inc. | $86.59M | $9.61 | — |
| OKYO | OKYO Pharma Ltd | $89.74M | $1.71 | — |
| SGMO | SANGAMO THERAPEUTICS, INC | $76.68M | $0.19 | — |
| LONA | LeonaBio, Inc. | $90.84M | $9.67 | — |
News headlines (Yahoo Finance, 1h cache)
Champions Oncology to Present New Data on Predicting Response and Resistance at AACR 2026
2026-04-09 17:40 · Yahoo
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
2026-03-30 14:55 · Yahoo
Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Highlights: Record Services Revenue and ...
2026-03-19 01:00 · Yahoo
Champions Oncology (CSBR) Earnings Transcript
2026-03-13 13:26 · Yahoo
Champions Oncology, Inc. Q3 2026 Earnings Call Summary
2026-03-13 12:30 · Yahoo
Champions Oncology Reports Revenue of $16.6 Million
2026-03-12 20:01 · Yahoo
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026
2026-03-05 20:00 · Yahoo
Fund Discloses $25 Million Braze Stock Investment Amid 60% Share Plunge
2026-02-20 16:39 · Yahoo
Battery Management Dumps $9 Million Zeta Stake as Shares Slide 38% Year Over Year
2026-02-20 16:29 · Yahoo
Battery Takes $124 Million Bet on Kodiak AI. Here's What Investors Should Know
2026-02-20 16:21 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.